Subramanian Nithya, Kanwar Jagat R, Athalya Prasanna Kumar, Janakiraman Narayanan, Khetan Vikas, Kanwar Rupinder K, Eluchuri Sailaja, Krishnakumar Subramanian
Department of Nanobiotechnology, Vision Research Foundation, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, 18 College Road, Chennai, 600006, Tamil Nadu, India.
Nanomedicine Laboratory of Immunology and Molecular Biomedical Research (LIMBR), School of Medicine (SoM), Molecular and Medical Research (MMR) Strategic Research Centre, Faculty of Health, Deakin University, Geelong, Victoria, 3217, Australia.
J Biomed Sci. 2015 Jan 9;22:4. doi: 10.1186/s12929-014-0108-9.
Epithelial cell adhesion molecule (EpCAM) is overexpressed in solid tumors and regarded as a putative cancer stem cell marker. Here, we report that employing EpCAM aptamer (EpApt) and EpCAM siRNA (SiEp) dual approach, for the targeted delivery of siRNA to EpCAM positive cancer cells, efficiently inhibits cancer cell proliferation.
Targeted delivery of siRNA using polyethyleneimine is one of the efficient methods for gene delivery, and thus, we developed a novel aptamer-PEI-siRNA nanocomplex for EpCAM targeting. PEI nanocomplex synthesized with EpCAM aptamer (EpApt) and EpCAM siRNA (SiEp) showed 198 nm diameter sized particles by dynamic light scattering, spherical shaped particles, of 151 ± 11 nm size by TEM. The surface charge of the nanoparticles was -30.0 mV using zeta potential measurements. Gel retardation assay confirmed the PEI-EpApt-SiEp nanoparticles formation. The difference in size observed by DLS and TEM could be due to coating of aptamer and siRNA on PEI nanocore. Flow cytometry analysis revealed that PEI-EpApt-SiEp has superior binding to cancer cells compared to EpApt or scramble aptamer (ScrApt) or PEI-ScrApt-SiEp. PEI-EpApt-SiEp downregulated EpCAM and inhibited selectively the cell proliferation of MCF-7 and WERI-Rb1 cells.
The PEI nanocomplex fabricated with EpApt and siEp was able to target EpCAM tumor cells, deliver the siRNA and silence the target gene. This nanocomplex exhibited decreased cell proliferation than the scrambled aptamer loaded nanocomplex in the EpCAM expressing cancer cells and may have potential for EpCAM targeting in vivo.
上皮细胞粘附分子(EpCAM)在实体瘤中过表达,被视为一种假定的癌症干细胞标志物。在此,我们报告采用EpCAM适配体(EpApt)和EpCAM小干扰RNA(SiEp)的双重方法,将小干扰RNA靶向递送至EpCAM阳性癌细胞,可有效抑制癌细胞增殖。
使用聚乙烯亚胺进行小干扰RNA的靶向递送是基因递送的有效方法之一,因此,我们开发了一种用于靶向EpCAM的新型适配体 - 聚乙烯亚胺 - 小干扰RNA纳米复合物。用EpCAM适配体(EpApt)和EpCAM小干扰RNA(SiEp)合成的聚乙烯亚胺纳米复合物通过动态光散射显示直径为198 nm的颗粒,通过透射电子显微镜观察为球形颗粒,大小为151±11 nm。使用zeta电位测量法测得纳米颗粒的表面电荷为 -30.0 mV。凝胶阻滞试验证实了聚乙烯亚胺 - EpApt - SiEp纳米颗粒的形成。动态光散射和透射电子显微镜观察到的尺寸差异可能是由于适配体和小干扰RNA包覆在聚乙烯亚胺纳米核上。流式细胞术分析表明,与EpApt或乱序适配体(ScrApt)或聚乙烯亚胺 - ScrApt - SiEp相比,聚乙烯亚胺 - EpApt - SiEp与癌细胞的结合能力更强。聚乙烯亚胺 - EpApt - SiEp下调了EpCAM的表达,并选择性地抑制了MCF - 7和WERI - Rb1细胞的增殖。
用EpApt和SiEp制备的聚乙烯亚胺纳米复合物能够靶向EpCAM肿瘤细胞,递送小干扰RNA并使靶基因沉默。在表达EpCAM的癌细胞中相比于加载乱序适配体的纳米复合物,这种纳米复合物表现出细胞增殖减少,并且可能在体内具有靶向EpCAM的潜力。